DNA methylation-based signatures classify sporadic pituitary tumors according to clinicopathological features
Abstract
Distinct genome-wide methylation patterns cluster pituitary neuroendocrine tumors (PitNETs) into molecular groups associated with specific clinicopathological features. Here we aim to identify, characterize, and validate methylation signatures that objectively classify PitNET into clinicopathological groups.
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Feb 25, 2021
- Source ID
- 10.1093/neuonc/noab044
Entities
People
- Abir Mukherjee
- Ana C. Decarvalho
- Ana Valeria Castro
- Felipe Segato Dezem
- Houtan Noushmehr
- Jack Rock
- James Snyder
- Karam P Asmaro
- Laila M. Poisson
- Margaret Castro
- Maritza S Mosella
- Michael Wells
- Paula C Elias
- Sonir R Antonini
- Steven Kalkanis
- Tathiane M. Malta
- Thais S Sabedot
- Tiago C Silva
- Tobias Walbert
- Todd Aho
Organizations
- Henry Ford Health
- National Institutes of Health
- São Paulo Research Foundation
- United States Department of Defense
- University of São Paulo